Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
- Vizimpro
Descriptions
Dacomitinib is used to treat non-small cell lung cancer that has spread (metastatic) with an epidermal growth factor receptor (EGFR) exon 19 deletion or exon 21 L858R substitution mutation gene. Your doctor will use a test to check for the mutation before you receive this medicine.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2019
Copyright © 2020 IBM Watson Health. Todos los derechos reservados. La información es de uso exclusivo para usuarios finales y se prohíbe su venta, redistribución o uso con fines comerciales.